Here are relevant reports on : cancer-surveillance-market
-
Cancer Supportive Care Drugs Market by Drug Class (G-CSFS, ESAS, Antiemetics, Bisphosphonates, Opioids, Nsaids), Cancer Type (Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer, Other Cancers) - Global Forecast to 2023
Cancer supportive care also known as palliative care is focused on relieving patients from side effects of cancer therapies. In cancer palliative care, supportive drugs are used to lessen the side effects of cancer treatments. In many cases cancer treatments need to be stopped or doses need to lowered due various reasons such as low blood cell counts. In such cases, cancer supportive drugs such as CSFs enable patients to continue with cancer treatments as well as in other cases, it also allows higher doses of cancer therapies. Cancer being one of the leading causes of death worldwide, there has been increasing focus on cancer treatments. Many cancer treatments comes with various side effects such as fatigue, pain, fertility problems, depression, heartburn, sexual problems, bone diseases and other side effects. With such side effects, there is preference to use supportive care drugs during cancer treatments. Such factors are expected to drive the cancer supportive care drugs market. However, there are some side effects associated with cancer supportive care drugs which may hinder the market growth.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Noninvasive Cancer Diagnostics Market by Instruments (Solid Tumor, Blood Cancer, Lung Cancer, Breast Cancer), Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics) - Analysis & Global Forecast to 2019
The global non-invasive cancer diagnostic market is expected to show considerable growth during the forecast period. This is attributed to growing cancer cases worldwide, especially breast and lung cancer. In 2013, in the U.S. there were more than 1,660,290 new cases of all type of cancers diagnosed in 2013 (American Cancer Society). Increased healthcare expenditure and increase research and development activities are some of the other factors driving the growth of this market. However factors such as high cost of treatment, and stringent regulatory guidelines are limiting the market growth.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) & Region - Global Forecast to 2028
The global antimicrobial resistance (AMR) surveillance market, valued at US$5.4 billion in 2021, stood at US$5.9 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$7.7 billion by the end of the period.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Trade Surveillance System Market by Application (Surveillance & Analytics, Risk & Compliance, Reports & Monitoring, Case Management) and End User (Financial Institutions, Capital Market, Digital Asset Exchange) - Global Forecast to 2030
The global trade surveillance system market is expected to grow substantially, projected to rise from USD 3.00 billion in 2025 to USD 5.90 billion by 2030, reflecting a CAGR of 14.5%. Some of the trade surveillance system vendors are NiCE (US), Nasdaq (US), FIS (US), IPC Systems (US), Nexi S.p.A (Italy), Crisil (India), ACA Group (US), Acuity Knowledge Partners (UK), LSEG (UK), and TradingHub (UK).
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Coastal Surveillance Market by Application (C2, Communication, Computers, Intelligence, Surveillance & Reconnaissance, and Electronic Warfare), End Use (Naval, Coast Guard), Structure (National, Regional, and Port), Scale - Global Forecast to 2035
The global Coastal Surveillance Market is estimated to reach approximately USD 10.20 billion in 2025 and is projected to grow to USD 21.60 billion by 2035, registering a CAGR of 7.8% during the forecast period. The market is witnessing steady growth driven by increasing maritime security threats, rising incidents of illegal fishing, smuggling, and piracy, and the growing need for effective coastal monitoring systems. Coastal surveillance systems integrate radar, electro-optical sensors, communication systems, and command centers to ensure real-time situational awareness across coastal regions. The integration of artificial intelligence (AI), Internet of Things (IoT), and automation is transforming coastal surveillance into intelligent, network-centric systems capable of predictive analytics, automated threat detection, and enhanced operational efficiency. Digital transformation across maritime security infrastructure, coupled with advancements in sensor fusion and unmanned systems, is significantly accelerating market growth globally.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Wireless Monitoring and Surveillance Market by Product (Cameras, Alarms), Devices (Wireless Monitoring, And Surveillance), Application (Healthcare, Security, Retail, Infrastructure, and Entertainment) & Geography -Forecast & Analysis to 2014 – 2020
The demand for security and better monitoring solutions has urged the need for better monitoring and surveillance devices. Wireless monitoring and surveillance devices play an important role for the deployment of improved security systems. The wireless monitoring systems helpsin monitoring such places where it is not feasible or convenient to include cables. Wireless organizations also play an important role for monitoring and controlling the wireless operations. The advantages offered by wireless monitoring and surveillance devices are improved security, high quality, and wide coverage range.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Automatic Dependent Surveillance Broadcast (ADS-B) Market by Type (On-Board, Ground Stations), Fit (Line, Retrofit), Platform (Fixed, Rotary), Component (Transponder, Receiver), Application (TMA, Airborne Surveillance), and Region - Global Forecast to 2022
The Automatic Dependent Surveillance-Broadcast (ADS-B) market is projected to grow from USD 427.8 Million in 2016 to USD 1,316.9 Million by 2022, at a CAGR of 20.61% during the forecast period. Implementation of ADS-B in aircraft serves to be one of the most significant factors driving the growth of the ADS-B market. Modernization of air traffic management infrastructure and development of new airports globally are additional factors propelling the demand for ADS-B. Increasing volume of UAVs in airspace has further led to the need for integrating unmanned aerial vehicles with air traffic control systems, which, in turn, is anticipated to drive the growth of the ADS-B market.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Cancer Diagnostics Market by Product (Consumables (Antibodies, Probes), Instruments), Technology (IVD Testing, Anatomic pathology, Imaging, Biopsy), Type (Tumors, Breast, Lung Cancer), Application, End User (Hospitals) & Region – Global Forecast to 2031
The global cancer diagnostics market is projected to reach USD 44.92 billion by 2031, growing at a CAGR of 7.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Immunotherapy Drugs Market by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
The global immunotherapy drugs market, valued at US$255.9 billion in 2023, stood at US$285.3 billion in 2024 and is projected to advance at a resilient CAGR of 15.3% from 2024 to 2029, culminating in a forecasted valuation of US$580.6 billion by the end of the period. This growth is driven by technological advancements in antibody engineering, increasing demand for antibody therapies in clinical cancer treatment, and a growing preference for personalized medicines and targeted therapies.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021
The global cancer immunotherapy market size is projected to grow at a CAGR of 14.0%. Market growth can be attributed to the increasing incidence of cancer, rising demand for therapies with minimal adverse effects, increase in adoption of immunotherapy over other treatment options, and enhanced drug development process. However, stringent regulatory policies and the highly consolidated market which may create an obstacle for the entry of small players are the major factors restraining the growth of this market.
- Published: September 2016
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
